Abstract
Background and objective: cervical cancer remains an over burden on health system in low to middle income countries worldwide. The early accurate staging and Histopathological morphology are vital to guide therapeutic decisions and predict better outcome. Methodology: This Retrospective Cohort study was conducted in the department of Oncology, AECH Norin Cancer Hospital Nawabshah combined with Department of Pathology, Peoples University of Medical and Health Sciences, from June 2015 to June 2025. All the medical record of histopathologically proven followed by immunohistochemistry and staged clinically according to the 2009 and 2018 revised International Federation of Gynecology and Obstetrics (FIGO) guideline for Cervical cancer, were collected on pre-designed proforma and carefully analyzed by using SPSS Version 25. Results: The registered number of patients with carcinoma cervix was 589, the mean age of patient was 55.5 years found in this study. The most common stage presented here were stage III (49.24%).The most common age group involved was 51 to 60 years age (28.86%). The most prevalent histological morphology is squamous cell carcinoma 82.3%, with 67% moderately differentiated grade. Conclusions: The disease is more prevalent in middle age and advance stage, Squamous cell carcinoma with grade II, moderately differentiated disease was found in this study.